Skip To Main Content
Jon Paras on Muck Rack

Jon Paras

As seen in: Clinical Leader
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jon

Contact Jon, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

07.19.23 -- How Sites Are Managing The Rising Costs Of DCTs

|
By Jon Paras, Stephan Lutzmayer, Medidata AI
| Clinical Leader Verified
You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences. Clinical Sites | Patient Centricity | Patient Recruitment (Monday) Clinical Trial Technology (Tuesday) Decentralized Trials | Trial Management (Wednesday) Outsourcing Models | Regulatory & Compliance (Thursday) (Friday) Learn more about our personalized newsletters here.
Open in Who Shared Issue with article?

03.07.23 -- Questions Sponsors Should Ask When Selecting Tech Vendors For DCTs

|
By Jon Paras, Robert Toal, Jackie Torres, Jason Fanelli Verified
| Clinical Leader Verified
Questions Sponsors Should Ask When Selecting Tech Vendors For DCTs Elevar Therapeutics’ Jennifer Lee, RSM US’s Steve Kemler, and Janssen Clinical Innovation’s Bert Hartog recently discussed the challenges of new technology implementation. Here, Lee provides her top questions sponsors should be asking themselves before choosing a technology vendor.
Open in Who Shared Issue with article?

Effective Use Of IRT In Decentralized And Hybrid Clinical Trials

|
By Jon Paras
| Clinical Leader Verified
Article | January 5, 2023 By Jon Paras, YPrime The increasingly complex protocols, disparate patient populations, and evolving needs of modern clinical trials have necessitated solutions geared toward simplifying, digitizing, and democratizing studies. Patient-centric trials, such as decentralized clinical trials (DCTs) and hybrid trials, have all emerged as potential answers to this complexity, owing to their flexibility when compared to traditional on-site studies.
Open in Who Shared Issue with article?
See all 3 articles